In vitro and in vivo comparative study of a novel 68Ga-labeled PSMA-targeted inhibitor and 68Ga-PSMA-11
Abstract 68Ga-radiolabeled small molecules that specifically target prostate-specific membrane antigen (PSMA) have been extensively investigated, and some of these tracers have been used in the diagnosis of prostate cancer via 68Ga-positron emission tomography (68Ga-PET). Nevertheless, current 68Ga-...
Main Authors: | Huanyu Chen, Ping Cai, Yue Feng, Zhanliang Sun, Yinwen Wang, Yue Chen, Wei Zhang, Nan Liu, Zhijun Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-09-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-98555-y |
Similar Items
-
Cyclotron-based production of 68Ga, [68Ga]GaCl3, and [68Ga]Ga-PSMA-11 from a liquid target
by: Melissa E. Rodnick, et al.
Published: (2020-11-01) -
Investigation of the halo-artifact in 68Ga-PSMA-11-PET/MRI.
by: Thorsten Heußer, et al.
Published: (2017-01-01) -
What to Trust, PSA or [68Ga]Ga-PSMA-11: Learn from Experience
by: Viglialoro R, et al.
Published: (2021-08-01) -
Radiation dosimetry of [68Ga]PSMA-11 in low-risk prostate cancer patients
by: Kristina Sandgren, et al.
Published: (2019-01-01) -
[<sup>68</sup>Ga]Ga-PSMA-11: The First FDA-Approved <sup>68</sup>Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
by: Ute Hennrich, et al.
Published: (2021-07-01)